Follow the Suven Life Sciences Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Suven Life Sciences Limited has published 4 reports. Market capitalisation: €88.5bn. The latest transaction was reported on 9 March 2026 (Purchase). Among the most active insiders: Jasti Property and Equity Holdings Private Limited. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Suven Life Sciences Limited is a company focused on the research and development of pharmaceuticals, primarily in the field of neurological and psychiatric disorders. It is listed on the Bombay Stock Exchange.